Adverse effects of the use of intravenous pentamidine in the home

Infectious Diseases in Clinical Practice

Volumn 5, Issue 7, 1996, Pages 456-458

  Gross, Robert ^a   Graziani, Amy L ^a   Laufer, David ^c   Turner, John L ^b   Ondercin, Joseph P ^b   MacGregor, Rob Roy ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b GRADUATE HOSPITAL   (United States)

^c Antelope Valley Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTAMIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; HOME CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGLYCEMIA; HYPOKALEMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PNEUMOCYSTIS PNEUMONIA; UNITED STATES;

EID: 0029969867     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199609000-00015     Document Type: Article

References (8)

1. Poretz, DM. Outpatient use of ceftriaxone: cost-benefit analysis. Am J Med 1984;77(4C Suppl):77S-83S.
2. Wagner DK. Long-term intravenous antibiotics in chronic osteomyelitis. Arch Intern Med 1985;145:1073-8.
3. Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev Infect Dis 1985,7:625-34.
4. Balslev U, Nielsen TL. Adverse effects associated with intravenous pentamidine isoethionate as treatment of Pneumocyitis carinii pneumonia in AIDS patients. Dan Med Bull 1992;39:366-8.
5. Eisenhauer MD, Eliasson AH, Taylor AJ, et al. Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest 1994;105:389-95.
6. Mello-Udine L. Home care of AIDS patients. New Jersey Medicine 1992;89:52-4.
7. Waskin H, Stehr-Green JK, Helmick CG, et al. Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. JAMA 1988;260:345-7.
8. Brown RB. Selecting the patient. Hosp Pract (Off Ed) 1993;28(1 Suppl):11S-15S.